Limited time75% off all plans
Get the app

Scleritis: Anterior

On this page

Scleritis: Anterior - Fiery Eye Facts

  • Severe, boring ocular pain, radiates (jaw/temple); deep violaceous hue.
  • Anterior Scleritis (~90% of cases):
    • Diffuse: Widespread inflammation; most common type.
    • Nodular: Firm, tender, immobile scleral nodule.
    • Necrotizing:
      • With inflammation: Most severe; extreme pain, high vision loss risk.
      • Without inflammation (Scleromalacia Perforans): Painless; typically in RA.
  • Photophobia, lacrimation. Systemic disease association in ~50% (e.g., RA, GPA). Anterior Scleritis with Violaceous Hue

⭐ Scleromalacia perforans: painless necrotizing scleritis in elderly RA patients; risk of globe perforation.

Scleritis: Anterior - Systemic Triggers

  • Often linked to systemic disease (approx. 50% of cases).
  • Connective Tissue Diseases (CTDs): Most frequent cause.
    • Rheumatoid Arthritis (RA): Most common CTD.
    • Granulomatosis with Polyangiitis (GPA).
    • Relapsing Polychondritis.
    • Systemic Lupus Erythematosus (SLE).
    • Inflammatory Bowel Disease (IBD).
  • Infections:
    • Tuberculosis, Syphilis, Herpes Zoster.
  • Other Systemic Conditions:
    • Sarcoidosis, Gout.

⭐ Rheumatoid Arthritis is the most common systemic disease associated with scleritis, particularly in women.

Scleritis: Anterior - Painful Red Alert

  • Severe, boring pain: Radiates (jaw, temple), worse at night, ↑ with eye movement.
  • Redness: Deep, violaceous hue; non-blanching with phenylephrine (2.5%).
  • Photophobia, lacrimation, ↓ vision possible.
  • Types:
    • Diffuse: Most common, widespread inflammation.
    • Nodular: Immobile, tender, erythematous nodule.
    • Necrotizing: Most severe; intense pain, risk of perforation.
      • With inflammation: Often underlying systemic vasculitis.
      • Without inflammation (Scleromalacia Perforans): Often painless, typically in Rheumatoid Arthritis (RA).
  • Systemic association (≈50%): RA, Granulomatosis with Polyangiitis (GPA), Inflammatory Bowel Disease (IBD). Anterior scleritis with deep violaceous redness

⭐ Necrotizing scleritis carries the worst prognosis, with the highest risk of scleral thinning and globe perforation, especially if associated with systemic vasculitis or scleromalacia perforans in RA patients.

Scleritis: Anterior - Spotting the Sore

  • Severe, boring pain (worse at night, radiates); photophobia; deep violaceous redness.
  • Types:
    • Diffuse: Most common; widespread inflammation.
    • Nodular: Immobile, tender, localized inflamed nodule.
    • Necrotizing: Most severe; avascular areas; high perforation risk.
  • Systemic disease link (~50%): RA, GPA, SLE.
  • Phenylephrine 10% test: Deep scleral vessels DON'T blanch (vs. episcleritis).
  • Workup: ESR, CRP, ANA, RF, ANCA. B-scan for posterior extension. ⭐ > Necrotizing scleritis carries the gravest prognosis and is often linked to systemic vasculitis.
  • Complications: ↓VA, sclerosing keratitis, uveitis, glaucoma.

Anterior scleritis with violaceous hue and engorged vessels

Scleritis: Anterior - Dousing the Flames

  • Goal: Control inflammation, relieve pain, prevent complications & vision loss.
  • Management Strategy: Stepped approach based on severity & type.
  • Complications: ↓ Vision, keratitis, uveitis, glaucoma, cataract, scleral thinning/perforation.

⭐ Approximately 50% of scleritis cases are associated with an underlying systemic autoimmune disease (e.g., RA, GPA).

High‑Yield Points - ⚡ Biggest Takeaways

  • Characterized by severe, boring ocular pain that radiates and worsens at night.
  • Frequently linked to systemic autoimmune conditions (e.g., RA, GPA).
  • Shows a distinctive deep, violaceous or bluish-red scleral hue.
  • Key diagnostic sign: Scleral vessels do not blanch with phenylephrine.
  • Necrotizing scleritis is the most destructive form, with perforation risk.
  • Scleromalacia perforans is a painless necrotizing type in RA.
  • Management necessitates systemic treatment (NSAIDs, steroids, immunosuppressants).

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE